trending Market Intelligence /marketintelligence/en/news-insights/trending/0Xqirf_jBafTGmYum8DRQg2 content esgSubNav
In This List

BioCryst Pharmaceuticals appoints board chairman

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


BioCryst Pharmaceuticals appoints board chairman

BioCryst Pharmaceuticals Inc. appointed Robert Ingram as chairman of its board of directors.

Ingram has been a member of the company's board since 2015. He replaces George Abercrombie, who will step down as chairman but continue to be a member of the board.